TALZENNA is supplied in strengths and package configurations as described in Table 12:
Package Configuration | Capsule Strength (mg) | NDC | |
Bottles of 30 capsules | 0.1 | NDC 0069-1031-30 | White cap (printed with “Pfizer” in black) and a white body (printed with “TLZ 0.1” in black). |
Bottles of 30 capsules | 0.25 | NDC 0069-0296-30 | Ivory cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 0.25" in black). |
Bottles of 30 capsules | 0.35 | NDC 0069-1235-30 | Ivory cap (printed with “Pfizer” in black) and an ivory body (printed with “TLZ 0.35” in black). |
Bottles of 30 capsules | 0.5 | NDC 0069-1501-30 | Light pink cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 0.5" in black). |
Bottles of 30 capsules | 0.75 | NDC 0069-1751-30 | Light orange cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 0.75" in black). |
Bottles of 30 capsules | 1 | NDC 0069-1195-30 | Light red cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 1" in black). |
TALZENNA is supplied in strengths and package configurations as described in Table 12:
Package Configuration | Capsule Strength (mg) | NDC | |
Bottles of 30 capsules | 0.1 | NDC 0069-1031-30 | White cap (printed with “Pfizer” in black) and a white body (printed with “TLZ 0.1” in black). |
Bottles of 30 capsules | 0.25 | NDC 0069-0296-30 | Ivory cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 0.25" in black). |
Bottles of 30 capsules | 0.35 | NDC 0069-1235-30 | Ivory cap (printed with “Pfizer” in black) and an ivory body (printed with “TLZ 0.35” in black). |
Bottles of 30 capsules | 0.5 | NDC 0069-1501-30 | Light pink cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 0.5" in black). |
Bottles of 30 capsules | 0.75 | NDC 0069-1751-30 | Light orange cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 0.75" in black). |
Bottles of 30 capsules | 1 | NDC 0069-1195-30 | Light red cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 1" in black). |
TALZENNA is supplied in strengths and package configurations as described in Table 12:
Package Configuration | Capsule Strength (mg) | NDC | |
Bottles of 30 capsules | 0.1 | NDC 0069-1031-30 | White cap (printed with “Pfizer” in black) and a white body (printed with “TLZ 0.1” in black). |
Bottles of 30 capsules | 0.25 | NDC 0069-0296-30 | Ivory cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 0.25" in black). |
Bottles of 30 capsules | 0.35 | NDC 0069-1235-30 | Ivory cap (printed with “Pfizer” in black) and an ivory body (printed with “TLZ 0.35” in black). |
Bottles of 30 capsules | 0.5 | NDC 0069-1501-30 | Light pink cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 0.5" in black). |
Bottles of 30 capsules | 0.75 | NDC 0069-1751-30 | Light orange cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 0.75" in black). |
Bottles of 30 capsules | 1 | NDC 0069-1195-30 | Light red cap (printed with "Pfizer" in black) and a white body (printed with "TLZ 1" in black). |
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Contact Medical Information.9AM-5PM ET Monday to Friday; excluding holidays.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.